Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tak-sui Wong"'
Autor:
Zongchao Yu, Yongping Lu, Mengxian Zhang, Yanshan Lin, Tak-sui Wong, Baozhang Guan, Yu Meng, Bo Hu, Fan-na Liu, Lianghong Yin, Yankun Li, Han Zhang, Donge Tang, Yong Dai
Publikováno v:
Proteome Science, Vol 22, Iss 1, Pp 1-11 (2024)
Abstract Diabetic nephropathy affects a significant proportion of individuals with diabetes, and its progression often leads to cardiovascular disease and infections before the need for renal replacement therapy arises. Empagliflozin has been shown t
Externí odkaz:
https://doaj.org/article/27554417ffd04b9f934c75126b1d18d3
Autor:
Tak-Sui Wong, Qian Chen, Taoran Liu, Jing Yu, Yangyang Gao, Yan He, Qiongqiong Zhong, Zijian Tan, Tinlun Liu, Jian Lu, Jian Huang, Casper J. P. Zhang, Lianghong Yin, Bo Hu, Wai-Kit Ming
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
BackgroundA patient-centered dialysis treatment option requires an understanding of patient preferences for alternative vascular accesses and nephrologists often face difficulties when recommending vascular access to end-stage kidney disease (ESKD) p
Externí odkaz:
https://doaj.org/article/9acc1bcb9a4f46768611f086d861ec1e
Autor:
Fu-li Shi, Li-sha Yuan, Tak-sui Wong, Qing Li, Ya-ping Li, Rong Xu, Yi-ping You, Tao Yuan, Hong-rui zhang, Zi-jian Shi, Qing-bing Zha, Bo Hu, Xian-hui He, Dong-yun Ouyang
Publikováno v:
Pharmacological Research, Vol 189, Iss , Pp 106697- (2023)
Necroptosis has been implicated in various inflammatory diseases including tumor-necrosis factor-α (TNF-α)-induced systemic inflammatory response syndrome (SIRS). Dimethyl fumarate (DMF), a first-line drug for treating relapsing-remitting multiple
Externí odkaz:
https://doaj.org/article/ce3aec9a4834464ab895dd0a7a4df808
Autor:
Tak-sui Wong, Qian Chen, Qiongqiong Zhong, Bo Hu, Guanrui Feng, Fengqiu Huang, Jian Lu, Lianghong Yin, Zongchao Yu, Babatunde O Akinwunmi, Jian Huang, Casper JP Zhang, Wai-kit Ming
Publikováno v:
The journal of vascular access.
Objectives: To evaluate the cost-effectiveness of three permanent vascular accesses for maintenance hemodialysis patients from a hospital perspective throughout 5 years, which is the average life expectancy of patients with end-stage kidney disease.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80e8b5df6dfbd155906270094e2b35b3
https://pubmed.ncbi.nlm.nih.gov/36540049
https://pubmed.ncbi.nlm.nih.gov/36540049
